top of page
Gotham__Trans Gotham White.png

FACITtrans Publications

OUR PASSION FOR LINGUISTICS IS WHAT DRIVES US

Below are selected publications and presentations by our staff, detailing the various approaches and challenges to attaining cross-cultural measurement equivalence.

PublicationsTop

Your search returned 0 results

A comprehensive method for the translation and cross-cultural validation of health status questionnaires.

Eremenco S., Arnold B., Cella D.

Evaluation & the Health Professions 2005; 28(2): 212-232.

Multilingual validation of the FACT-Leukemia in 7 languages.

Eremenco S., Arnold B., Cella D.

Value in Health 2005; 8(6): A47.

Equivalence: What clients need and what translators need to know.

Bredle J.M., Herzberg T.

ATA Chronicle 2005; 32(4): 25-27.

Gender inclusive language: How much is too much?

Herzberg T., Bredle J.M.

Presentation at the American Translators Association (ATA) Conference, Toronto, ON, 2004.

Development and multilingual validation of the FACT-Lymphoma instrument.

Eremenco S., Webster K., Kutikova L., Bowman L., Cella D.

Quality of Life Research 2004; 13(9): 1501.

Equivalence: What clients need and what translators need to know.

Bredle J.M., Herzberg T.

Presentation at the American Translators Association (ATA) Conference, Toronto, ON, 2004.

Benefits and consequences of using a single Portuguese language version of the Functional Assessment of Cancer Therapy-General (FACT-G).

Arnold B., Eremenco S., Lai J.S., Ribeiro J., Doro M., Cella D.

Quality of Life Research 2004; 13(9): 1546.

Health-related quality of life in patients with early multiple sclerosis in the BEST study.

Cella D., Kappos L., Eremenco S., Kaskel P., Miltenburger C.

Journal of Neurology 2004; 252(Suppl II): II/40.

FACT-Gastric: A new international measure of QOL in gastric cancer.

Eremenco S.L., Cashy J., Webster K., Ohashi Y., Locker G.Y., Pelletier G., Cella D.

Journal of Clinical Oncology 2004; 22(14S): 759.

The Functional Assessment of Cancer Therapy-BRM (FACT-BRM): A new tool for the assessment of quality of life in patients treated with biologic response modifiers.

Bacik J., Mazumdar M., Murphy B., Fairclough D., Eremenco S., Mariani T., Motzer R., Cella D.

Quality of Life Research 2004; 13(1): 137-154.

We look forward to serving your study needs. Contact us to get started!

​

FACITtrans is ISO 9001:2015 and ISO 17100:2015 certified.
ISOLogo_modified-02.png
ATCC-ISO17100_2015-Mark-INVERT (1).png
bottom of page